{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "MEDESIS PHARMA SA EO 2,-", "longName": "Medesis Pharma S.A.", "messageBoardId": "finmb_112205500", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "fullExchangeName": "Frankfurt", "regularMarketOpen": 1.825, "averageDailyVolume3Month": 8, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.17299998, "fiftyTwoWeekLowChangePercent": 0.10285373, "fiftyTwoWeekRange": "1.682 - 3.79", "fiftyTwoWeekHighChange": -1.935, "fiftyTwoWeekHighChangePercent": -0.5105541, "fiftyTwoWeekLow": 1.682, "fiftyTwoWeekHigh": 3.79, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.64, "sharesOutstanding": 4390340, "fiftyDayAverage": 2.4671, "fiftyDayAverageChange": -0.6120999, "fiftyDayAverageChangePercent": -0.24810502, "twoHundredDayAverage": 2.605715, "twoHundredDayAverageChange": -0.750715, "twoHundredDayAverageChangePercent": -0.28810328, "marketCap": 8527843, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Medesis Pharma SA", "nameChangeDate": "2023-05-11", "tradeable": false, "cryptoTradeable": false, "regularMarketChangePercent": -1.5915104, "regularMarketPrice": 1.855, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1613545200000, "priceHint": 4, "regularMarketChange": -0.029999971, "regularMarketTime": 1683892036, "regularMarketDayHigh": 1.855, "regularMarketDayRange": "1.825 - 1.855", "regularMarketDayLow": 1.825, "regularMarketVolume": 500, "regularMarketPreviousClose": 1.885, "bid": 1.855, "ask": 2.08, "symbol": "76D.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "L\u2019Or\u00e9e des Mas", "address2": "B\u00e2t. Les Cypr\u00e8s Avenue du Golf Baillargues", "city": "Montpellier", "zip": "34670", "country": "France", "phone": "33 4 67 03 03 96", "website": "https://www.medesispharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Medesis Pharma S.A. operates as a biopharmaceutical company. The company's products include NanoLithium (NP03) for the treatment of Alzheimer's disease; NanosiRNA HD and NanoP42T to treat Huntington's disease; NanoLithium for the prevention and treatment of psychiatric disorders; NanoManganese (NP02), a radiation protection drug; and NU01 plutonium decorporation and NU02 cesium decorporation nuclear drugs. It also develops oncology drugs, including NanosiRNA IFNAR and NanoManganese Radiotherapy Glioblastoma. The company was founded in 2003 and is based in Montpellier, France.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Jean-Claude  Maurel", "title": "CEO, Pres & Member of Management Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Solene  Guilliot", "title": "Chief Medical Officer, Head of R&D and Member of the Exec. Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mario  Alcaraz", "title": "Gen. Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}